Literature DB >> 8282885

CT attenuation values and enhancing characteristics of thoracoabdominal lymphomatous adenopathies.

F Pombo1, E Rodriguez, M V Caruncho, C Villalva, C Crespo.   

Abstract

OBJECTIVE: Thoracoabdominal lymphomatous adenopathies have been described as homogeneous and typically showing little enhancement on postcontrast CT. After observing pronounced adenopathic contrast enhancement in one patient with lymphoma, we prospectively investigated the CT enhancing characteristics and attenuation values of pathologic thoracic and abdominal lymph nodes in 25 patients with lymphoma.
MATERIALS AND METHODS: Unenhanced CT of the chest, abdomen and pelvis was performed in all cases. The enhancing characteristics and attenuation values of the largest node or group of nodes were evaluated at 1, 2, 5, and 10 min after a 100 ml intravenous bolus injection of contrast medium.
RESULTS: On unenhanced CT the nodes were of soft-tissue attenuation (42 +/- 5 HU) in 23 cases and of low attenuation (31 and 28 HU) in 2 cases. The maximum enhancement was achieved at 1 or 2 min postinjection and was low (16 +/- 6 HU) or moderate (31 +/- 6 HU) in 21 cases and pronounced (61 +/- 5 HU) in 4. The patterns of enhancement were classified as homogeneous (no. = 23) inhomogeneous (no. = 1), and peripheral (no. = 1).
CONCLUSION: Thoracic and abdominal lymphomatous adenopathies are usually of soft-tissue attenuation on unenhanced CT and can show slight, moderate, or even pronounced enhancement on postcontrast CT.

Entities:  

Mesh:

Year:  1994        PMID: 8282885     DOI: 10.1097/00004728-199401000-00013

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  7 in total

Review 1.  Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  Sarah J Vinnicombe; Rodney H Reznek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-23       Impact factor: 9.236

2.  Characterization of mesothelioma and tissues present in contrast-enhanced thoracic CT scans.

Authors:  Neal Corson; William F Sensakovic; Christopher Straus; Adam Starkey; Samuel G Armato
Journal:  Med Phys       Date:  2011-02       Impact factor: 4.071

3.  Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  Christian la Fougère; Walter Hundt; Nicole Bröckel; Thomas Pfluger; Alexander Haug; Bernhard Scher; Marcus Hacker; Klaus Hahn; Maximilan Reiser; Reinhold Tiling
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-21       Impact factor: 9.236

4.  Tuberculosis versus non-Hodgkin's lymphomas involving small bowel mesentery: evaluation with contrast-enhanced computed tomography.

Authors:  Peng Dong; Bin Wang; Quan-Ye Sun; Hui Cui
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

5.  Tuberculous abscess in hepatoduodenal ligament: evaluation with contrast-enhanced computed tomography.

Authors:  Peng Dong; Bin Wang; Ye-Quan Sun
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

Review 6.  Imaging of abdominal nodal spread in malignant disease.

Authors:  S Delorme; G van Kaick
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

7.  Anterior mediastinal Hodgkin lymphoma presenting as an extremely hypervascular tumor on computed tomography: A case report.

Authors:  Soo Jeong Lee; Ji Young Rho; Gwang Il Kim; Joonsuk Park
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.